✦ LIBER ✦

Candidate targets for antibody therapy of rheumatoid arthritis: CD64 and IL-15

✍ Scribed by J van de Winkel

Book ID: 120708104
Publisher: BioMed Central
Year: 2003
Tongue: English
Weight: 554 KB
Volume: 5
Category: Article
ISSN: 1478-6354
DOI: 10.1186/ar843

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Different roles for anti–cyclic citrulli

Different roles for anti–cyclic citrullinated peptide antibodies and CD4+CD28null cells in the acceleration of atherosclerosis in rheumatoid arthritis: Comment on the article by Farragher et al

✍ Roberto Gerli; Gaetano Vaudo; Elena Bartoloni Bocci; Giuseppe Schillaci; Onelia 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 43 KB 👁 2 views

Golimumab, a human anti–tumor necrosis f

Golimumab, a human anti–tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: Twenty-four–week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis

✍ Paul Emery; Roy M. Fleischmann; Larry W. Moreland; Elizabeth C. Hsia; Ingrid Str 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB 👁 1 views

Study of active controlled tocilizumab m

Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy

✍ Norihiro Nishimoto; Nobuyuki Miyasaka; Kazuhiko Yamamoto; Shinichi Kawai; Tsutom 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 250 KB

Erratum: Golimumab, a human anti-tumor n

Erratum: Golimumab, a human anti-tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: Twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis

✍ Paul Emery; Roy M. Fleischmann; Larry W. Moreland; Elizabeth C. Hsia; Ingrid Str 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB 👁 1 views